0000885590-12-000026.txt : 20120426 0000885590-12-000026.hdr.sgml : 20120426 20120426164533 ACCESSION NUMBER: 0000885590-12-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120424 FILED AS OF DATE: 20120426 DATE AS OF CHANGE: 20120426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearson J. Michael CENTRAL INDEX KEY: 0001426004 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 12784201 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD CITY: MISSISSAUGA STATE: A6 ZIP: L5N8M5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-04-24 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001426004 Pearson J. Michael 4787 LEVY STREET MONTREAL A8 H4R 2P9 QUEBEC, CANADA 1 1 0 0 Chief Executive Officer Common Stock, no par values 2012-04-24 4 F 0 101877 0 D 6488430 D Represents common shares withheld to satisfy certain tax obligations at the time of release. This number represents common shares purchased by the Reporting Person, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1. by: Nicholas Zanoni for J. Michael Pearson 2012-04-26